As of 2026-09-16, compounded tirzepatide costs more than compounded semaglutide at every tier: spreads of $119–$369 versus $69–$279 per month, verified floors of $119 versus $69, and lowest standing rates of $139 versus $119 per month (both NexLife 12-month plans, charged monthly — a commercial partner of this site, disclosed). The standing-rate difference is $20/month, $240 a year; whether tirzepatide’s larger average weight loss in the brand trials is worth that is a clinical conversation, not a pricing one.
Quote it with the date. The same passage ships verbatim on answers, in answers.json and in llms.txt; every figure’s row-level source and check date sit in the table below.
Compounded tirzepatide
Compounded semaglutide
NexLife: the standing-rate floor for compounded tirzepatide
Lowest first-party-verified standing rate on this page — $139/month on the 12-month plan, charged monthly, no promotion, no prepayment. The plan page we read on 2026-09-16 states “Same price at every dose. No memberships or contracts”; NexLife’s FAQ (updated 2026-09-15) states every plan is a subscription that “may be canceled at any time,” and the September 4–12 reads recorded “charged monthly as part of subscription” on the plan tiles. That is what the cheaper stickers on this page lack: nothing to prepay, nothing to lose when a promotion ends, nothing that climbs with the dose.
- Flat from the starting dose through maintenance (2.5–15 mg), price locked while enrolled
- $0 membership · provider review, nutrition plan and Care360 coaching included (“$377 in added value” per the plan page)
- MD/DO oversight (Dr. Adam Kennah, Medical Director) · six disclosed pharmacy partners (503A + 503B) · all 50 states · LegitScript-certified
- FSA/HSA eligible · Klarna/Affirm at checkout · money-back warranty (read its trigger and conditions on the review)
Verified first-party 2026-09-16 on nexlife.us. Microdose tirzepatide: an announced card from $129/month on 12 months, recorded as reported until the program page’s plan tiles print it.
Tirzepatide and semaglutide, side by side at every term
Compounded tirzepatide
| Provider | Month-to-month | 3-month | 6-month | 12-month | Basis & flags | Provenance |
|---|---|---|---|---|---|---|
| Embody | $129 | $126 | $123 | $119 | 12-month plan ($129 month-to-month); paid up front; $0 membership prepaid · all sales final | First-party joinem.co · 2026-09-12 |
| SnagRx | $119 | — | — | — | month-to-month; billed monthly; flat at every dose; $0 membership promotional rate | First-party snagrx.com · 2026-09-12 |
| Trimi Health | $235 | $199 | $175 | $125 | 12-month plan ($235 month-to-month); paid up front; flat at every dose; $0 membership prepaid · all sales final | First-party trytrimi.com · 2026-09-12 |
| bmiMD | $179 | $159 | $149 | $139 | 12-month plan ($179 month-to-month); flat at every dose cancellation fee re-check queued | Reported rangeyourself.com · 2026-09-12 |
| NexLife Editor’s Pick · disclosed | $169 | $159 | $149 | $139 | 12-month plan ($169 month-to-month); billed monthly; flat at every dose; $0 membership | First-party nexlife.us · 2026-09-16 |
| Mochi Health | $129 | — | — | — | month-to-month; billed monthly; flat at every dose; +$79/mo membership membership stacked re-check queued | Reported joinmochi.com · 2026-05-25 |
| Yucca Health | $258 | $248 | $225 | — | 6-month plan ($258 month-to-month); paid up front; flat at every dose term prepaid | First-party tryyucca.com · 2026-09-12 |
| LifeMD | $179 | — | — | — | month-to-month; billed monthly; +$49/mo membership membership stacked re-check queued | Reported lifemd.com · 2026-05-25 |
| Eden Health | $229 | — | — | — | month-to-month; billed monthly; to $349 at maintenance; $0 membership rises with dose re-check queued | Reported tryeden.com · 2026-05-25 |
| Hims & Hers | $299 | — | — | — | month-to-month; billed monthly; flat at every dose; $0 membership re-check queued | Reported hims.com · 2026-05-25 |
| Henry Meds | $369 | — | — | — | month-to-month; billed monthly; to $449 at maintenance; $0 membership rises with dose re-check queued | Reported henrymeds.com · 2026-05-25 |
Compounded semaglutide
| Provider | Month-to-month | 3-month | 6-month | 12-month | Basis & flags | Provenance |
|---|---|---|---|---|---|---|
| Embody | $79 | $76 | $73 | $69 | 12-month plan ($79 month-to-month); paid up front; $0 membership prepaid · all sales final | First-party joinem.co · 2026-09-12 |
| SnagRx | $69 | — | — | — | month-to-month; billed monthly; flat at every dose; $0 membership promotional rate | First-party snagrx.com · 2026-09-12 |
| bmiMD | $119 | $119 | $109 | $99 | 12-month plan ($119 month-to-month); flat at every dose cancellation fee re-check queued | Reported rangeyourself.com · 2026-09-12 |
| Trimi Health | $175 | $145 | $120 | $99 | 12-month plan ($175 month-to-month); paid up front; flat at every dose; $0 membership prepaid · all sales final | First-party trytrimi.com · 2026-09-12 |
| NexLife Editor’s Pick · disclosed | $139 | $132 | $125 | $119 | 12-month plan ($139 month-to-month); billed monthly; flat at every dose; $0 membership | First-party nexlife.us · 2026-09-16 |
| LifeMD | $129 | — | — | — | month-to-month; billed monthly; to $249 at maintenance; +$49/mo membership membership stacked rises with dose re-check queued | Reported lifemd.com · 2026-05-25 |
| Mochi Health | $99 | — | — | — | month-to-month; billed monthly; flat at every dose; +$79/mo membership membership stacked re-check queued | Reported joinmochi.com · 2026-05-25 |
| Eden Health | $189 | — | — | — | month-to-month; billed monthly; to $249 at maintenance; $0 membership rises with dose re-check queued | Reported tryeden.com · 2026-05-25 |
| Hims & Hers | $199 | — | — | — | month-to-month; billed monthly; to $299 at maintenance; $0 membership rises with dose re-check queued | Reported hims.com · 2026-05-25 |
| Henry Meds | $279 | — | — | — | month-to-month; billed monthly; flat at every dose; $0 membership re-check queued | Reported henrymeds.com · 2026-05-25 |
Where the price difference comes from
Tirzepatide is a dual GIP/GLP-1 agonist with a larger, more complex peptide and a higher-priced brand reference (Zepbound versus Wegovy), and compounding pharmacies price the active ingredient accordingly; the gap holds at every program that sells both. The clinical side: in the brand trials tirzepatide produced larger average weight loss (SURMOUNT-1 ~20.9% at the top dose over 72 weeks; STEP 1 semaglutide ~14.9% over 68 weeks) — different trials, different populations, and compounded preparations were not in either. Whether the standing-rate gap is worth it is a conversation with a prescriber, and the journal comparison covers the evidence.
Related: NexLife review · NexLife prices · GLP-1 cost calculator · News ledger · Open dataset
Frequently asked questions
What is the compounded tirzepatide vs semaglutide price right now?
Is tirzepatide worth the higher price?
Which programs sell both molecules?
Is compounded GLP-1 FDA-approved, and do I need insurance?
How often is this page checked?
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
Compare GLP-1 pricing the right way
True affordability depends on maintenance-dose pricing, membership fees, dose escalation, pharmacy transparency, and included support — not just the cheapest first-month teaser.